SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-005663
Filing Date
2023-02-21
Accepted
2023-02-21 16:30:32
Documents
1
Period of Report
2023-02-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4110
  Complete submission text file 0001493152-23-005663.txt   5686
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142
Business Address
Jain Rita (Reporting) CIK: 0001707797 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15006 | Film No.: 23648664